| Zhang, Ying |
| Active, not recruiting | 3 | 1470 | RoW | VABB Elite 10G, BARD 14G CNB | Fudan University | Breast Cancer | 12/21 | 06/22 | | |
NCT03388593: Survival Study of the Recombinant Human Neuregulin-1β in Subjects With Chronic Heart Failure. |
|
|
| Recruiting | 3 | 1600 | RoW | rhNRG-1, Neucardin™, Placebo | Zensun Sci. & Tech. Co., Ltd. | Chronic Heart Failure | 02/26 | 02/26 | | |
NCT03236636: The Phase III Study of Icaritin Versus HUACHANSU PIAN in Hepatocellular Carcinoma Subjects |
|
|
| Recruiting | 3 | 312 | RoW | Icaritin, SNG-162, HUACHANSU PIAN, HUACHANSU PIAN（999） | Beijing Shenogen Biomedical Co., Ltd, Chinese Academy of Medical Sciences, NanJing PLA 81 Hospital, Peking University Cancer Hospital & Institute, Beijing Hospital, Guang'anmen Hospital of China Academy of Chinese Medical Sciences, Jinan Central Hospital, Linyi Tumour Hospital, The First Affiliated Hospital of Anhui Medical University, Anhui Provincial Hospital, The First Affiliated Hospital with Nanjing Medical University, The Affiliated Tumor Hospital of Nantong University, Nantong, Jiangsu Province, China, Nanfang Hospital of Southern Medical University, First People's Hospital of Foshan, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Hebei Medical University Fourth Hospital, The First Hospital of Jilin University, Haikou People's Hospital, Fudan University, West China Hospital, Chongqing Traditional Chinese Medicine Hospital, Chifeng Municipal Hospital, The Affiliated Hospital of Hangzhou Normal University, The First Affiliated Hospital of Zhengzhou University, Guilin Medical University, China, The Third Xiangya Hospital of Central South University, Yunnan Provincial Hospital of Traditional Chinese Medicine, The Sixth People's Hospital of Shenyang | Advanced HBV-Related Hepatocellular Carcinoma (HCC) | 12/22 | 12/22 | | |
| Active, not recruiting | 3 | 466 | Europe, Canada, Japan, US, RoW | tucatinib, ONT-380, placebo, T-DM1, Kadcyla | Seagen Inc., Seagen Inc., Seattle Genetics, Inc., Seagen Inc | HER2-positive Breast Cancer | 06/23 | 10/27 | | |
|
|
TQB2102-III-01, NCT06561607: A Clinical Trial to Evaluate the Efficacy and Safety of TQB2102 for Injection Versus Investigator-Selected Chemotherapy in HER2 Low-Expressing Recurrent/Metastatic Breast Cancer |
|
|
| Not yet recruiting | 3 | 542 | RoW | TQB2102 for Injection, Chemotherapy drug (Capecitabine/Paclitaxel/Albumin Paclitaxel) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Breast Cancer | 01/27 | 12/28 | | |
NCT06696261: A Study of Lianxiaxiaopi Granules in the Treatment of Postprandial Distress Syndrome |
|
|
| Not yet recruiting | 3 | 342 | RoW | Lianxiaxiaopi Granules, a simulated agent of Lianxiaxiaopi Granules | Tasly Pharmaceutical Group Co., Ltd | Postprandial Distress Syndrome | 06/26 | 08/26 | | |
NCT04263298: Fulvestrant Versus Capecitabine as Maintenance Therapy After First-line Chemotherapy in Patients With HR+/HER2- Metastatic Breast Cancer |
|
|
| Recruiting | 3 | 210 | RoW | Fulvestrant, Experimental group, Capecitabine Oral Product, Active Comparator control group | Herui Yao | Metastatic Breast Cancer | 05/25 | 05/30 | | |
| Recruiting | 3 | 472 | RoW | Qingzhu Granules, Qingzhu Granules Placebo | Tasly Pharmaceutical Group Co., Ltd | Gouty Arthritis | 10/25 | 10/25 | | |
NCT04651140: Research on the Effect and Mechanism of Aerobic Exercise on PD |
|
|
| Enrolling by invitation | N/A | 30 | RoW | aerobic exercise | First Hospital of Jilin University | Parkinson's Disease, Physical Exercise | 10/21 | 10/21 | | |
| Recruiting | N/A | 350 | RoW | FFR-guided PCI, Functionally complete revascularization, Intravascular ultrasound | Tianjin Chest Hospital | Non-ST-segment Acute Coronary Syndrome | 10/23 | 10/25 | | |
NCT04920214: Application Value of CEUS Li-RADS in Hepatic Focal Lesions in Patients With Non-high Risk Factors for HCC |
|
|
| Recruiting | N/A | 500 | RoW | SonoVue | Second Affiliated Hospital, School of Medicine, Zhejiang University, Tianjin Third Central Hospital, Sichuan Provincial People's Hospital, Fujian Cancer Hospital, Shandong Jining No.1 People's Hospital, General Hospital of Ningxia Medical University, Beijing Hospital, Red Cross Hospital, Hangzhou, China, Zhejiang Cancer Hospital, Shengjing Hospital | Hepatocellular Carcinoma | 12/23 | 12/23 | | |
NCT05782881: High Risk Population of Cardiovascular Disease in Hubei Province Screening and Intervention Program |
|
|
| Recruiting | N/A | 16000 | RoW | phone calls and encouraging patients' lifestyle change and medication adherence, Statin, Angiotensin-converting enzyme inhibitor, Angiotensin receptor neprilysin inhibitor, Glucagon-like peptide-1, Sodium-dependent glucose transporters 2 | Wuhan Union Hospital, China, Peking University First Hospital | Cardiovascular Diseases, Diabetes Mellitus, Type 2, Coronary Disease | 12/23 | 12/24 | | |
| Not yet recruiting | N/A | 1500 | RoW | adrenal venous sampling | Chinese Academy of Medical Sciences, Fuwai Hospital | Hyperaldosteronism | 12/26 | 12/26 | | |
WML, NCT06608251: Association of Plasma Metabolomic Biomarkers with Chronic Ischemic White Matter Injury |
|
|
| Active, not recruiting | N/A | 100 | RoW | white matter lesion | Nanjing First Hospital, Nanjing Medical University | Myelinopathy | 05/25 | 05/25 | | |
NCT06591078: Evaluation of Clinical Efficacy of Acupuncture in Improving Immune Response in Patients With Cervical Cancer |
|
|
| Not yet recruiting | N/A | 90 | NA | electropuncture | Ying Zhang, Peking Union Medical College Hospital, Beijing Obstetrics and Gynecology Hospital, Peking University Cancer Hospital & Institute, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Sichuan Cancer Hospital and Research Institute, Shanghai University of Traditional Chinese Medicine, Hunan Cancer Hospital, Chongqing University Cancer Hospital | Cervical Cancer | 11/26 | 11/26 | | |
| Recruiting | N/A | 3500 | RoW | Without any intervention | Beijing Tiantan Hospital, Beijing Daxing District People Hospital | Cerebral Microvascular Dysfunction, Cerebral Small Vessel Diseases, Cognitive Dysfunction, Cerebrovascular Disorders, Cardiovascular Diseases, Population | 03/32 | 10/32 | | |
NCT06606509: The Survey of Treatment and Metabolic Status of Type 1 Diabetes Mellitus (T1DM). |
|
|
| Not yet recruiting | N/A | 1000 | RoW | Continuous Glucose Monitoring System (GX-01S) | Nanjing First Hospital, Nanjing Medical University | Type1 Diabetes Mellitus | 10/26 | 06/27 | | |
